RPG Life Sciences Acquires Raghava Life Sciences' API Biz

•RPG Active Pharma acquires Raghava Life Sciences' API and intermediates business for up to Rs 135 crore.

•Acquisition includes 22 commercialized APIs and 7 development-stage assets across various therapeutic segments.

•RPG Active Pharma aims to strengthen its integrated API play and manufacturing footprint through the deal.

•Transaction to be funded through a recent equity raise by RPG Active Pharma.